194 related articles for article (PubMed ID: 32410403)
1. Systematic Review of Studies Assessing the Health-Related Quality of Life of Hepatocellular Carcinoma Patients from 2009 to 2018.
Kang D; Shim S; Cho J; Lim HK
Korean J Radiol; 2020 Jun; 21(6):633-646. PubMed ID: 32410403
[TBL] [Abstract][Full Text] [Related]
2. Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis.
Palmieri VO; Santovito D; Margari F; Lozupone M; Minerva F; Di Gennaro C; Todarello O; Palasciano G
Clin Exp Med; 2015 Feb; 15(1):65-72. PubMed ID: 24323278
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life evaluated by tumor node metastasis staging system in patients with hepatocellular carcinoma.
Qiao CX; Zhai XF; Ling CQ; Lang QB; Dong HJ; Liu Q; Li MD
World J Gastroenterol; 2012 Jun; 18(21):2689-94. PubMed ID: 22690079
[TBL] [Abstract][Full Text] [Related]
4. Surgery and transplantation for hepatocellular cancer.
Wall WJ; Marotta PJ
Liver Transpl; 2000 Nov; 6(6 Suppl 2):S16-22. PubMed ID: 11084080
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage.
Plentz RR; Tillmann HL; Kubicka S; Bleck JS; Gebel M; Manns MP; Rudolph KL
J Gastroenterol Hepatol; 2005 Sep; 20(9):1422-8. PubMed ID: 16105131
[TBL] [Abstract][Full Text] [Related]
6. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
[TBL] [Abstract][Full Text] [Related]
7. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.
Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W
Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatocellular carcinoma with Child-Pugh C cirrhosis.
Nouso K; Kokudo N; Tanaka M; Kuromatsu R; Nishikawa H; Toyoda H; Oishi N; Kuwaki K; Kusanaga M; Sakaguchi T; Morise Z; Kitai S; Kudo M
Oncology; 2014; 87 Suppl 1():99-103. PubMed ID: 25427740
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.
Sanoff HK; Chang Y; Lund JL; O'Neil BH; Dusetzina SB
Oncologist; 2016 Sep; 21(9):1113-20. PubMed ID: 27185615
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal alterations in health-related quality of life and its impact on the clinical course of patients with advanced hepatocellular carcinoma receiving sorafenib treatment.
Shomura M; Kagawa T; Okabe H; Shiraishi K; Hirose S; Arase Y; Tsuruya K; Takahira S; Mine T
BMC Cancer; 2016 Nov; 16(1):878. PubMed ID: 27835949
[TBL] [Abstract][Full Text] [Related]
11. Important and relevant symptoms including pain concerns in hepatocellular carcinoma (HCC): a patient interview study.
Kaiser K; Mallick R; Butt Z; Mulcahy MF; Benson AB; Cella D
Support Care Cancer; 2014 Apr; 22(4):919-26. PubMed ID: 24258355
[TBL] [Abstract][Full Text] [Related]
12. Impact of hepatocellular carcinoma on health related quality of life in Egyptian patients: a single centre study.
Hamdy H; Fathy Barakat EM; El Folly RF
J Egypt Soc Parasitol; 2013 Apr; 43(1):183-94. PubMed ID: 23697025
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.
Giannini E; Risso D; Botta F; Romagnoli P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Testa R
J Intern Med; 2004 Mar; 255(3):399-408. PubMed ID: 14871465
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma.
Patt YZ; Hassan MM; Lozano RD; Brown TD; Vauthey JN; Curley SA; Ellis LM
J Clin Oncol; 2003 Feb; 21(3):421-7. PubMed ID: 12560429
[TBL] [Abstract][Full Text] [Related]
16. [Association of liver cirrhosis, hepatitis B virus infection and hepatocellular carcinoma--immunohistochemical study].
Knezević-Usaj S; Marković-Lipkovski J; Jovanović R
Vojnosanit Pregl; 1992; 49(5):432-8. PubMed ID: 1336256
[TBL] [Abstract][Full Text] [Related]
17. Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series.
Kambhampati S; Bauer KE; Bracci PM; Keenan BP; Behr SC; Gordan JD; Kelley RK
Cancer; 2019 Sep; 125(18):3234-3241. PubMed ID: 31154669
[TBL] [Abstract][Full Text] [Related]
18. Advanced hepatocellular carcinoma: A regional cancer center experience of 48 cases.
Lokesh KN; Chaudhuri T; Lakshmaiah KC; Babu KG; Dasappa L; Jacob LA; Suresh Babu MC; Rudresha AH; Rajeev LK
Indian J Cancer; 2017; 54(3):526-529. PubMed ID: 29798951
[TBL] [Abstract][Full Text] [Related]
19. [Surgical treatment of hepatocellular carcinoma].
Patiutko IuI; Chuchuev ES; Gakhramanov AD; Sagaĭdak IV; Kotel'nikov AG; Podluzhnyĭ DV; Abgarian MG; Poliakov AN; Konovalov AM
Klin Khir; 2011 Sep; (9):26-30. PubMed ID: 22168020
[TBL] [Abstract][Full Text] [Related]
20. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.
Farinati F; Rinaldi M; Gianni S; Naccarato R
Cancer; 2000 Dec; 89(11):2266-73. PubMed ID: 11147597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
